Vitamin D and depression — is the autumn blues caused by a lack of sunshine?

Aim of the study: Mood changes that follow the seasons occur to varying degrees among people, with anxiety and depression increasing during the winter months. An extreme form of seasonality is seen in the clinical syndrome of seasonal affective disorder (SAD), which also involves carbohydrate cravings, excessive sleep, lethargy, and changes in circadian rhythms.

Results: It has been suggested that seasonality and the symptoms of SAD may be due to changing levels of vitamin D3, the hormone of sunlight, leading to changes in brain serotonin. Forty-four healthy subjects were given 400 IU, 800 IU, or no vitamin D3 for 5 days during late winter in a random double-blind study. Results on a self-report measure showed that vitamin D3 significantly enhanced positive affect and there was some evidence of a reduction in negative affect. Results are discussed in terms of their implications for seasonality, SAD, serotonin, food preference, sleep, and circadian rhythms.

Aim of the study: Few studies have examined whether vitamin D insufficiency is linked with depression in healthy young women, despite the high rates of both problems among women. Female undergraduates (n=185) living in the Pacific Northwest during fall, winter, and spring academic terms completed the Center for Epidemiologic Studies Depression (CES-D) scale weekly for 4 weeks (W1-W5).

Results: Winter and Spring) were explained by their higher levels of vitamin D3. W1 depressive symptoms did not predict change in vitamin D3 levels from W1 to W5. Findings are consistent with a temporal association between low levels of vitamin D and clinically meaningful depressive symptoms. The preventive value of supplementation should be tested further.

Aim of the study: This integrative review evaluates research studies that investigated the association between vitamin D and mood disorders affecting women to determine whether further research comparing these variables is warranted. A literature search using CINAHL, PsycINFO, MEDLINE, and PubMed databases was conducted to locate peer-reviewed mood disorder research studies that measured serum 25-hydroxyvitamin D (25[OH]D) levels.

Results: This integrative review evaluates research studies that investigated the association between vitamin D and mood disorders affecting women to determine whether further research comparing these variables is warranted. A literature search using CINAHL, PsycINFO, MEDLINE, and PubMed databases was conducted to locate peer-reviewed mood disorder research studies that measured serum 25-hydroxyvitamin D (25[OH]D) levels. Four of six studies reviewed reported significant results, with all four showing an association between low 25(OH)D levels and higher rates of four mood disorders: premenstrual syndrome, seasonal affective disorder, unspecified mood disorder, and major depressive disorder. This review indicates a possible biochemical mechanism between vitamin D and mood disorders affecting women, warranting further studies of these variables using rigorous methods.

Aim of the study: Vitamin D plays a significant role in calcium and bone mineral metabolism and also affects cardiovascular, psychological, and cognitive functions. The ultraviolet B radiation component of sunlight, which shows marked seasonal variation in Antarctica, influences the synthesis of vitamin D. Depression and mood disorders are associated with this extreme photoperiod.

Results: Mild vitamin D deficiency was present in two (10 %) subjects on arrival, which increased to seven (35 %) subjects during the polar winter at 6 months. The mean score on the BDI-II screen for depression was significantly higher during midwinter (4.8 ± 3.9) when compared with the baseline value (2.9 ± 2.1). Only 2/20 (10 %) of subjects met the criteria for minor depression. Higher PTH levels at 6 months correlated with a higher PANAS X score (p = 0.021). The mean values of calcium, inorganic phosphorus, and ALP were comparable during the course of the expedition. Low light exposure during the dark polar winter, lower vitamin D, and increased intact PTH levels were found to be associated with depression during 1 year of Antarctic residence. The low dietary intake and decreased solar radiation exposure during the polar winter reduce serum vitamin D levels in otherwise healthy individuals, which suggests that supplementation may be necessary.

Aim of the study: The implication of vitamin D in the pathophysiology of depression has generated interest regarding its role as a biomarker in the context of mental health. Given the limited data on this association in the Romanian population, the present study aimed to evaluate the correlation between vitamin D status and the severity of depressive symptomatology in a sample of adult patients from Romania.

Results: A statistically significant negative association was identified for the BDI-II scale (B = -0.3170444, β = -0.2621328, p = 0.007) and the HAM-D17 scale (B = -0.1495026, β = -0.2829461, p = 0.002), which remained robust after adjustment for covariates (BDI-II: B = -0.2110473, β = -0.1744942, p = 0.050; HAMD17: B = -0.1153659, β = -0.2183397, p = 0.018). In comparison with subjects with vitamin D deficiency, those with sufficient levels presented a significantly lower probability of belonging to higher severity categories of depression for both scales (BDI-II: coefficient = -0.6855429, p = 0.004; HAM-D17: coefficient = -0.7029572, p = 0.005). The study highlighted a statistically significant negative correlation between vitamin D status and depression severity, which remained after adjustment for covariates. Sufficient vitamin D levels were associated with a significantly lower probability of belonging to a higher depression severity category compared with deficiency.

Aim of the study: Major depressive disorder (MDD) is a common psychiatric condition characterized by depressive symptoms and suicide-related clinical features. Vitamin D status has been investigated as a potential clinical correlate of depression and suicidal ideation, but the direction and specificity of these associations remain uncertain.

Results: Vitamin D deficiency was observed in 61.9% of participants and the mean serum 25(OH)D level was 18.4 ± 11.9 ng/mL. Lower serum 25(OH)D levels were significantly associated with higher HDRS, SIS, and SPS total/subscale scores. In adjusted models, higher serum 25(OH)D levels remained inversely associated with HDRS scores, SIS scores, and total SPS scores. Parental status was also associated with lower SIS scores, while a history of suicide attempts was associated with higher SPS-Suicidal Ideation scores. Lower serum 25(OH)D levels were associated with greater depressive symptom severity and higher suicide-related scale scores in adults with MDD, particularly across cognitive-affective domains relevant to suicide probability.

Aim of the study: While recent laboratory-based studies have substantially advanced our understanding of the action of vitamin D in the brain, much is still unknown concerning how vitamin D relates to mood. The few epidemiological studies of vitamin D and depression have produced inconsistent results and generally have had substantial methodological limitations.

Results: The few epidemiological studies of vitamin D and depression have produced inconsistent results and generally have had substantial methodological limitations. Recent findings from a randomized trial suggest that high doses of supplemental vitamin D may improve mild depressive symptoms, but important questions persist concerning how vitamin D may affect monoamine function and hypothalamic-pituitary-adrenal axis response to stress, whether vitamin D supplementation can improve mood in individuals with moderate-to-severe depression, and whether vitamin D sufficiency is protective against incident depression and recurrence. At this time, it is premature to conclude that vitamin D status is related to the occurrence of depression. Additional prospective studies of this relationship are essential.

Aim of the study: Depression affects 5% of the global population, posing significant health and economic challenges. This study evaluates the efficacy of vitamin D supplementation in reducing depressive symptoms and explores its dose-response relationship.

Results: The outcomes were reported in 15 studies encompassing data from 962 participants. Vitamin D supplementation demonstrated a significant improvement in depressive symptoms compared to the placebo group (SMD: -0.98; 95% CI - 1.28 to -0.68; p < 0.001). Statistical heterogeneity was high (I2 = 79%; p < 0.001). Secondary outcomes revealed significant reductions in serum PTH (MD: -4.19; 95% CI - 8.18 to -0.2 pg./mL) and TNFα levels (MD: -0.3; 95% CI - 0.44 to -0.16 pg./mL) in the intervention groups, while other outcomes, such as BMI, weight, and IL-6, showed no significant changes. Dose-response analysis further highlighted that higher daily doses of vitamin D, particularly up to 5,000 IU/day, were associated with the greatest reduction in depressive symptoms. Our findings from this systematic review and meta-analysis indicated that vitamin D supplementation may be an effective adjunctive therapy for improving depressive symptoms.

Aim of the study: Vitamin D deficiency and depressive disorders are both common in patients with eating disorders (EDs). However, the association between vitamin D status and current depressive disorder (CDD) in EDs populations remains insufficiently explored.

Results: Vitamin D deficiency was significantly associated with higher odds of CDD (OR 1.98, 95% CI 1.20-3.28; p = 0.008). This association persisted after adjustment for EDs severity, psychiatric comorbidities, and season of assessment. No significant interactions were found between vitamin D deficiency and eating-disorder subtype, EDE-Q score, or season. Vitamin D deficiency was associated with the presence of a current depressive disorder in patients with eating disorders, independently of EDs subtype, severity, and seasonality. These findings support the clinical relevance of assessing vitamin D status in patients with EDs presenting with depressive symptoms. Longitudinal studies are needed to clarify the direction and clinical implications of this association.